Warning Letter Roundup: Facilities Slammed for CGMP Violations

Drug GMP Report
A A
The FDA issued warning letters to four drugmakers over various CGMP violations at their facilities, some of which created risks of product contamination.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $40.00